Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

Effect of Gastric Bypass on Type 2 Diabetes and/or Dyslipidemia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00879125

Enrollment

219

Registered

2009-04-09

Start date

1999-11-30

Completion date

2007-11-30

Last updated

2009-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Gastric by-pass on patients with T2DM

Brief summary

This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.

Detailed description

Review and record changes in the subject's medication. subjects vitals: weight, blood pressure, and fasting blood values, which include: * HbA1c * Fasting blood glucose * Fasting Insulin * Lipid Panel ( total cholesterol, LDL, HDL and triglycerides) were obtained.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to 66 Years

Healthy volunteers

Inclusion criteria

Patients who have had diabetes and/or dyslipidemia prior to gastric by-pass. -

Exclusion criteria

Patients who have had type 2 diabetes that was diet controlled at time of surgery; and debilitated patients who are unable to come in for a physical exam. \-

Design outcomes

Primary

Measure	Time frame
glycemic control	one year

Secondary

Measure	Time frame
Correction of lipid profiles	one year

Countries

United States

Outcome results